Implant replacement and anaplastic large cell lymphoma associated with breast implants: a quantitative analysis.

anaplastic large cell lymphoma associated with breast implants breast implants replacement epidemiology quantitative analysis time to disease onset treatment outcomes

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 21 04 2023
accepted: 28 09 2023
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: epublish

Résumé

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare form of non-Hodgkin T-cell lymphoma associated with breast reconstruction post-mastectomy or cosmetic-additive mammoplasty. The increasing use of implants for cosmetic purposes is expected to lead to an increase in BIA-ALCL cases. This study investigated the main characteristics of the disease and the factors predicting BIA-ALCL onset in patients with and without an implant replacement. A quantitative analysis was performed by two independent researchers on cases extracted from 52 primary studies (case report, case series, and systematic review) published until April 2022 and searched in PubMed, Scopus, and Google-Scholar databases using "Breast-Implant" AND/OR "Associated" AND/OR "Anaplastic-Large-Cell-Lymphoma". The statistical significance was verified by Student's Overall, 232 patients with BIA-ALCL were extracted. The mean age at diagnosis was 55 years old, with a mean time to disease onset from the first implant of 10.3 years. The hazard of developing BIA-ALCL in a shorter time resulted significantly higher for patients not having an implant replacement (hazard ratio = 0.03; 95%CI: 0.005-0.19; Our findings suggest that, in BIA-ALCL patients, the implant substitution and/or capsulectomy may delay the disease's onset. However, the risk of reoccurrence in an earlier time should be considered in these patients. Moreover, the time to BIA-ALCL onset slightly increased with age. Selection bias, lack of awareness, misdiagnosis, and limited data availability could be identified as limits of our study. An implant replacement should be considered according to a risk stratification approach to delay the BIA-ALCL occurrence in asymptomatic patients, although a stricter follow-up after the implant substitution should be recommended. https://www.crd.york.ac.uk/PROSPERO, identifier: CRD42023446726.

Identifiants

pubmed: 37927474
doi: 10.3389/fonc.2023.1202733
pmc: PMC10622658
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

1202733

Informations de copyright

Copyright © 2023 Vittorietti, Mazzola, Costantino, De Bella, Fruscione, Bonaccorso, Sciortino, Costanza, Belluzzo, Savatteri, Tramuto, Contiero, Tagliabue, Immordino, Vitale, Di Napoli and Mazzucco.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Oncotarget. 2018 Nov 16;9(90):36126-36136
pubmed: 30546832
Am J Surg Pathol. 2012 Jul;36(7):1000-8
pubmed: 22613996
J Hematop. 2009 Aug 20;2(4):237-44
pubmed: 20309431
Plast Reconstr Surg. 2011 Sep;128(3):112e-118e
pubmed: 21775924
Aesthetic Plast Surg. 2018 Apr;42(2):451-455
pubmed: 29101436
Int J Mol Sci. 2021 May 21;22(11):
pubmed: 34063828
J Invest Surg. 2017 Feb;30(1):56-65
pubmed: 27537783
Virchows Arch. 2006 Nov;449(5):561-4
pubmed: 16983530
Regul Toxicol Pharmacol. 2021 Oct;125:104982
pubmed: 34214611
Plast Reconstr Surg. 2012 Apr;129(4):610e-617e
pubmed: 22456375
Aesthet Surg J. 2023 Apr 10;43(5):545-555
pubmed: 36441968
Am Surg. 2010 Sep;76(9):1030-1
pubmed: 20836362
Leukemia. 2022 Jul;36(7):1720-1748
pubmed: 35732829
Aesthet Surg J. 2021 Apr 12;41(5):NP214-NP222
pubmed: 33367520
Leuk Lymphoma. 2002 Jan;43(1):115-9
pubmed: 11908714
Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
Autoimmun Rev. 2019 May;18(5):556-557
pubmed: 30844557
Plast Reconstr Surg. 2021 Jan 1;147(1):30e-41e
pubmed: 33370049
Cancers (Basel). 2020 Dec 21;12(12):
pubmed: 33371292
Leuk Lymphoma. 2011 Aug;52(8):1481-7
pubmed: 21699454
Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e568-e572
pubmed: 31383476
J Pathol Transl Med. 2020 Sep;54(5):432-434
pubmed: 32806883
Breast. 2012 Feb;21(1):102-4
pubmed: 21840718
Mod Pathol. 2008 Apr;21(4):455-63
pubmed: 18223553
Clin Breast Cancer. 2013 Dec;13(6):492-5
pubmed: 24267734
Arch Pathol Lab Med. 2003 Mar;127(3):e115-8
pubmed: 12653596
Virchows Arch. 2018 Oct;473(4):505-511
pubmed: 29637270
Proc (Bayl Univ Med Cent). 2017 Oct;30(4):441-442
pubmed: 28966458
Cytopathology. 2018 Jun;29(3):294-299
pubmed: 29633403
J Clin Oncol. 2016 Jan 10;34(2):160-8
pubmed: 26628470
J La State Med Soc. 2013 Jan-Feb;165(1):26-9
pubmed: 23550394
Arch Plast Surg. 2020 Sep;47(5):478-482
pubmed: 32713177
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell L):51S-58S
pubmed: 30817556
Am J Surg Pathol. 2008 Aug;32(8):1265-8
pubmed: 18594466
JAMA. 2008 Nov 5;300(17):2030-5
pubmed: 18984890
Arch Pathol Lab Med. 2009 Sep;133(9):1383-90
pubmed: 19722744
PLoS One. 2017 Jul 17;12(7):e0181097
pubmed: 28715445
Diagn Cytopathol. 2019 Nov;47(11):1213-1217
pubmed: 31348611
Aesthetic Plast Surg. 2013 Jun;37(3):567-71
pubmed: 23620008
Ann Surg. 2020 Sep 1;272(3):403-409
pubmed: 32694446
Aesthet Surg J. 2011 May;31(4):467-8
pubmed: 21551441
Can J Plast Surg. 2013 Summer;21(2):95-8
pubmed: 24431950
Science. 2019 Nov 1;366(6465):
pubmed: 31672865
BMJ Case Rep. 2013 Nov 27;2013:
pubmed: 24285813
Case Reports Plast Surg Hand Surg. 2019 Apr 2;6(1):116-120
pubmed: 32002457
Eur J Surg Oncol. 2017 Aug;43(8):1393-1401
pubmed: 28596034
JAMA Netw Open. 2021 Sep 1;4(9):e2125381
pubmed: 34542618
Ann Plast Surg. 2007 Jul;59(1):56-7
pubmed: 17589261
J Plast Reconstr Aesthet Surg. 2013 Dec;66(12):1773-6
pubmed: 23751975
Plast Reconstr Surg. 1997 Aug;100(2):554-5
pubmed: 9252643
Aesthet Surg J. 2019 Jun 21;39(7):NP253-NP258
pubmed: 30768141
Br J Haematol. 2018 Mar;180(5):741-744
pubmed: 27859003
Plast Reconstr Surg. 2019 May;143(5):1298-1306
pubmed: 31033810
Case Rep Genet. 2019 Jul 16;2019:5647940
pubmed: 31392066
Front Aging. 2022 Sep 21;3:1018119
pubmed: 36213345
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Plast Reconstr Surg. 2020 Aug;146(2):255-267
pubmed: 32740572
Front Oncol. 2022 Dec 06;12:1052057
pubmed: 36561514
Acta Med Port. 2021 Aug 31;34(9):572-579
pubmed: 33512315
Breast Cancer. 2020 May;27(3):499-504
pubmed: 32095988
Leuk Lymphoma. 2009 May;50(5):831-3
pubmed: 19330656
Annu Rev Public Health. 1999;20:145-57
pubmed: 10352854
Clin Case Rep. 2018 Feb 16;6(4):634-637
pubmed: 29636930
Breast J. 2019 Jan;25(1):69-74
pubmed: 30521149
Ann Plast Surg. 2022 Feb 1;88(2):157-161
pubmed: 34270472
Aesthetic Plast Surg. 2020 Apr;44(2):286-294
pubmed: 31844943
Eur J Breast Health. 2021 Oct 04;17(4):302-307
pubmed: 34651107
Radiol Case Rep. 2020 Aug 01;15(10):1736-1742
pubmed: 32774571
Int J Clin Exp Pathol. 2009 Oct 15;3(1):117-27
pubmed: 19918336
Ann Diagn Pathol. 2020 Jun;46:151512
pubmed: 32315816
Int J Clin Exp Pathol. 2013 Jul 15;6(8):1631-42
pubmed: 23923082
Dtsch Arztebl Int. 2018 Sep 21;115(38):628-635
pubmed: 30373708
Ann Oncol. 2016 Feb;27(2):306-14
pubmed: 26598546
Histopathology. 2015 Dec;67(6):925-7
pubmed: 25974645
Ann Chir Plast Esthet. 2013 Dec;58(6):688-93
pubmed: 23707084
Ann Plast Surg. 2022 Feb 1;88(2):152-156
pubmed: 34711728
Diagn Cytopathol. 2022 Jan;50(1):E1-E5
pubmed: 34623773
Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell L):30S-40S
pubmed: 30817554
Blood. 2020 Jan 30;135(5):360-370
pubmed: 31774495
J Plast Reconstr Aesthet Surg. 2018 Jun;71(6):785-787
pubmed: 29776552
J Oncol Pract. 2017 Dec;13(12):838-839
pubmed: 28945505
Plast Reconstr Surg. 2020 Nov;146(5):530e-538e
pubmed: 32852469
Aesthet Surg J. 2017 Sep 1;37(8):887-891
pubmed: 29036945
Diagn Pathol. 2018 Jan 25;13(1):10
pubmed: 29370815
Diagn Pathol. 2009 Apr 02;4:11
pubmed: 19341480
J Plast Reconstr Aesthet Surg. 2020 May;73(5):841-846
pubmed: 32008941
Plast Reconstr Surg. 2021 Aug 1;148(2):299-303
pubmed: 34133406
Rev Med Chil. 2020 Aug;148(8):1207-1212
pubmed: 33399788
Blood. 2020 Dec 17;136(25):2927-2932
pubmed: 33331925

Auteurs

Martina Vittorietti (M)

SEAS Department, University of Palermo, Palermo, Italy.

Sergio Mazzola (S)

U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, Palermo, Italy.

Claudio Costantino (C)

U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, Palermo, Italy.
PROMISE Department, University of Palermo, Palermo, Italy.

Daniele Domenico De Bella (DD)

PROMISE Department, University of Palermo, Palermo, Italy.

Santo Fruscione (S)

PROMISE Department, University of Palermo, Palermo, Italy.

Nicole Bonaccorso (N)

PROMISE Department, University of Palermo, Palermo, Italy.

Martina Sciortino (M)

PROMISE Department, University of Palermo, Palermo, Italy.

Davide Costanza (D)

PROMISE Department, University of Palermo, Palermo, Italy.

Miriam Belluzzo (M)

PROMISE Department, University of Palermo, Palermo, Italy.

Alessandra Savatteri (A)

PROMISE Department, University of Palermo, Palermo, Italy.

Fabio Tramuto (F)

U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, Palermo, Italy.
PROMISE Department, University of Palermo, Palermo, Italy.

Paolo Contiero (P)

Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Giovanna Tagliabue (G)

Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Palmira Immordino (P)

PROMISE Department, University of Palermo, Palermo, Italy.

Francesco Vitale (F)

U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, Palermo, Italy.
PROMISE Department, University of Palermo, Palermo, Italy.

Arianna Di Napoli (A)

Department of Clinical and Molecular Medicine, University of Rome "Sapienza", Rome, Italy.

Walter Mazzucco (W)

U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, Palermo, Italy.
PROMISE Department, University of Palermo, Palermo, Italy.
College of Medicine, University of Cincinnati, Cincinnati, OH, United States.

Classifications MeSH